National Research Corp
Research National Research Corp (NRC) on Bullrun: valuation model: 42.9% overvalued, market cap USD 487.69M, P/E 55.5, dividend yield 2.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNRC
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyUSD
- Valuation signal42.9% overvalued
- Market capUSD 487.69M
- P/E55.5
- Dividend yield2.8%
- Financial periodFY2025
- RevenueUSD 137.39M
- Revenue growth-4.0%
- Net incomeUSD 11.60M
- Free cash flowUSD 15.74M
Valuation Snapshot
Bullrun's latest valuation model marks National Research Corp as 42.9% overvalued; latest market cap is USD 487.69M; P/E is 55.5; dividend yield is 2.8%.
About National Research Corp
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments.
Frequently asked questions
Is National Research Corp overvalued or undervalued?
Bullrun's valuation model currently marks National Research Corp as 42.9% overvalued.
What is National Research Corp's market cap?
National Research Corp's market capitalization is USD 487.69M.
What is National Research Corp's P/E ratio?
National Research Corp's price-to-earnings (P/E) ratio is 55.5.
Does National Research Corp pay a dividend?
National Research Corp has a dividend yield of 2.8%.
What does National Research Corp do?
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States.